Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Nicola A. Hanania et al.|New England Journal of Medicine|2023Cited by 452
Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR StudyJeremy Cole, Gene Colice|Pulmonary Therapy|2023Cited by 3